4.7 Article

Effects of DBS in parkinsonian patients depend on the structural integrity of frontal cortex

期刊

SCIENTIFIC REPORTS
卷 7, 期 -, 页码 -

出版社

NATURE PORTFOLIO
DOI: 10.1038/srep43571

关键词

-

资金

  1. German Research Council [SFB 1193]
  2. Medtronic Inc.
  3. St. Judes Inc
  4. Boston Scientific
  5. Abbott
  6. Orion
  7. Lundbeck
  8. Medtronic
  9. Desitin
  10. Teva
  11. Pfizer
  12. German Research Council
  13. German Ministry of Education and Health

向作者/读者索取更多资源

While deep brain stimulation of the subthalamic nucleus (STN-DBS) has evolved to an evidencebased standard treatment for Parkinson's disease (PD), the targeted cerebral networks are poorly described and no objective predictors for the postoperative clinical response exist. To elucidate the systemic mechanisms of DBS, we analysed cerebral grey matter properties using cortical thickness measurements and addressed the dependence of structural integrity on clinical outcome. Thirty one patients with idiopathic PD without dementia (23 males, age: 63.4 +/- 9.3, Hoehn and Yahr: 3.5 +/- 0.8) were selected for DBS treatment. The patients underwent whole-brain preoperative T1 MR-Imaging at 3 T. Grey matter integrity was assessed by cortical thickness measurements with FreeSurfer. The clinical motor outcome markedly improved after STN-DBS in comparison to the preoperative condition. The cortical thickness of the frontal lobe (paracentral area and superior frontal region) predicted the clinical improvement after STN-DBS. Moreover, in patients with cortical atrophy of these areas a higher stimulation voltage was needed for an optimal clinical response. Our data suggest that the effects of STN-DBS in PD directly depend on frontal lobe grey matter integrity. Cortical atrophy of this region might represent a distinct predictor of a poor motor outcome after STN-DBS in PD patients.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据